scholarly journals Calcium Orthophosphate Bioceramics

2010 ◽  
Vol 12 (3,4) ◽  
pp. 247 ◽  
Author(s):  
Sergey V. Dorozhkin
Keyword(s):  
Tissue Engineering ◽  
Current Knowledge ◽  
Calcium Orthophosphate ◽  
Human Beings ◽  
Artificial Bone ◽  
Special Significance ◽  
Metallic Implants ◽  
Calcium Orthophosphates ◽  
Porous Bioceramic ◽  
Calcified Tissues

The present review is intended to point the readers’ attention to the important subject of calcium orthophosphate bioceramics. Calcium orthophosphates by one-selves appear to be of a special significance for the human beings because they represent the inorganic part of calcified tissues of mammals. Therefore, many types of calcium orthophosphate-based bioceramics possess remarkable biocompatibility and bioactivity. Materials scientists extensively use this property in attempts to construct artificial bone grafts those are either entirely made of or only surface-coated by calcium orthophosphate bioceramics. Namely, self-setting calcium orthophosphate cements are very helpful in filling voids in damaged bones, while metallic implants covered by a surface layer of calcium orthophosphate bioceramics are widely used for hip joint endoprostheses and tooth substitutes. Porous bioceramic scaffolds made of calcium orthophosphates are very promising tools for tissue engineering applications. In this paper, an overview on the current knowledge on calcium orthophosphate bioceramics has been provided.

Functionalized calcium orthophosphates (CaPO4) and their biomedical applications

2019 ◽  
Vol 7 (47) ◽  
pp. 7471-7489 ◽  
Author(s):  
Sergey V. Dorozhkin
Keyword(s):  
Biomedical Applications ◽  
Bone Grafts ◽  
Artificial Bone ◽  
Chemical Similarity ◽  
Calcium Orthophosphates ◽  
Calcified Tissues

Due to the chemical similarity to natural calcified tissues (bones and teeth) of mammals, calcium orthophosphates (abbreviated as CaPO4) appear to be good biomaterials for creation of artificial bone grafts.

Amorphous Calcium Phosphates

2010 ◽  
Vol 7 ◽  
pp. 27-53 ◽  
Author(s):  
Sergey V. Dorozhkin
Keyword(s):  
Structural Unit ◽  
Calcium Phosphates ◽  
Matrix Vesicle ◽  
Calcium Orthophosphate ◽  
Artificial Bone ◽  
Preparation Conditions ◽  
Calcium Orthophosphates ◽  
Wide Range ◽  
Variable Chemical ◽  
Dry Conditions

Amorphous calcium phosphates (ACPs) represent a unique class of biomedically relevant calcium orthophosphate salts, in which there are neither translational nor orientational long-range orders of the atomic positions. Nevertheless, the constancy in their chemical composition over a relatively wide range of preparation conditions suggests the presence of a well-defined local structural unit, presumably, with the structure of Ca9(PO4)6 – so-called Posner’s cluster. ACPs have variable chemical but rather identical glass-like physicochemical properties. Furthermore, all ACPs are thermodynamically unstable compounds and, unless stored in dry conditions or doped by stabilizers, spontaneously they tend to transform to crystalline calcium orthophosphates. Although some order within general disorder is the most distinguishing feature of ACPs, the solution instability of ACPs and their easy transformation to crystalline phases might be of a great biological relevance. Namely, the initiating role ACPs play in matrix vesicle biomineralization raises the importance of this phase from a mere laboratory curiosity to that of a key intermediate in skeletal calcification. Furthermore, ACPs are very promising candidates to manufacture artificial bone grafts.

scholarly journals The Role of Major Histocompatibility Complex in Organ Transplantation- Donor Specific Anti-Major Histocompatibility Complex Antibodies Analysis Goes to the Next Stage -

2019 ◽  
Vol 20 (18) ◽  
pp. 4544 ◽  
Author(s):  
Tsukasa Nakamura ◽  
Takayuki Shirouzu ◽  
Katsuya Nakata ◽  
Norio Yoshimura ◽  
Hidetaka Ushigome
Keyword(s):  
Major Histocompatibility Complex ◽  
Organ Transplantation ◽  
Current Knowledge ◽  
Human Leukocyte ◽  
Strongly Correlated ◽  
Human Beings ◽  
Major Histocompatibility ◽  
Antibody Mediated Rejection ◽  
Leukocyte Antigens ◽  
Histocompatibility Complex

Organ transplantation has progressed with the comprehension of the major histocompatibility complex (MHC). It is true that the outcome of organ transplantation largely relies on how well rejection is managed. It is no exaggeration to say that to be well acquainted with MHC is a shortcut to control rejection. In human beings, MHC is generally recognized as human leukocyte antigens (HLA). Under the current circumstances, the number of alleles is still increasing, but the function is not completely understood. Their roles in organ transplantation are of vital importance, because mismatches of HLA alleles possibly evoke both cellular and antibody-mediated rejection. Even though the control of cellular rejection has improved by recent advances of immunosuppressants, there is no doubt that antibody-mediated rejection (AMR), which is strongly correlated with donor-specific anti-HLA antibodies (DSA), brings a poor outcome. Thus, to diagnose and treat AMR correctly is a clear proposition. In this review, we would like to focus on the detection of intra-graft DSA as a recent trend. Overall, here we will review the current knowledge regarding MHC, especially with intra-graft DSA, and future perspectives: HLA epitope matching; eplet risk stratification; predicted indirectly recognizable HLA epitopes etc. in the context of organ transplantation.

scholarly journals 3D-Bioprinting Strategies Based on In Situ Bone-Healing Mechanism for Vascularized Bone Tissue Engineering

Micromachines ◽  
2021 ◽  
Vol 12 (3) ◽  
pp. 287
Author(s):  
Ye Lin Park ◽  
Kiwon Park ◽  
Jae Min Cha
Keyword(s):  
Tissue Engineering ◽  
Bone Tissue Engineering ◽  
Bone Tissue ◽  
Bone Healing ◽  
Critical Size ◽  
Current Knowledge ◽  
3D Bioprinting ◽  
The Past ◽  
Regeneration Processes

Over the past decades, a number of bone tissue engineering (BTE) approaches have been developed to address substantial challenges in the management of critical size bone defects. Although the majority of BTE strategies developed in the laboratory have been limited due to lack of clinical relevance in translation, primary prerequisites for the construction of vascularized functional bone grafts have gained confidence owing to the accumulated knowledge of the osteogenic, osteoinductive, and osteoconductive properties of mesenchymal stem cells and bone-relevant biomaterials that reflect bone-healing mechanisms. In this review, we summarize the current knowledge of bone-healing mechanisms focusing on the details that should be embodied in the development of vascularized BTE, and discuss promising strategies based on 3D-bioprinting technologies that efficiently coalesce the abovementioned main features in bone-healing systems, which comprehensively interact during the bone regeneration processes.

scholarly journals Today Prospects for Tissue Engineering Therapeutic Approach in Dentistry

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Maurizio Bossù ◽  
Andrea Pacifici ◽  
Daniele Carbone ◽  
Gianluca Tenore ◽  
Gaetano Ierardo ◽  
...  
Keyword(s):  
Tissue Engineering ◽  
Stem Cells ◽  
Current Knowledge ◽  
Dental Stem Cells ◽  
Therapeutic Tool ◽  
Exponential Increase ◽  
Major Interest ◽  
Adult Mesenchymal Stem Cells ◽  
Therapeutic Protocols ◽  
Near Future

In dental practice there is an increasing need for predictable therapeutic protocols able to regenerate tissues that, due to inflammatory or traumatic events, may suffer from loss of their function. One of the topics arising major interest in the research applied to regenerative medicine is represented by tissue engineering and, in particular, by stem cells. The study of stem cells in dentistry over the years has shown an exponential increase in literature. Adult mesenchymal stem cells have recently been isolated and characterized from tooth-related tissues and they might represent, in the near future, a new gold standard in the regeneration of all oral tissues. The aim of our review is to provide an overview on the topic reporting the current knowledge for each class of dental stem cells and to identify their potential clinical applications as therapeutic tool in various branches of dentistry.

scholarly journals A Three-Dimensional Collagen-Elastin Scaffold for Heart Valve Tissue Engineering

2018 ◽  
Vol 5 (3) ◽  
pp. 69 ◽  
Author(s):  
Xinmei Wang ◽  
Mir Ali ◽  
Carla Lacerda
Keyword(s):  
Tissue Engineering ◽  
Endothelial Cells ◽  
Heart Valves ◽  
Current Knowledge ◽  
Three Dimensional ◽  
Stimuli Responsive ◽  
Integrin Β1 ◽  
Mesenchymal Transition ◽  
3D Collagen

Since most of the body’s extracellular matrix (ECM) is composed of collagen and elastin, we believe the choice of these materials is key for the future and promise of tissue engineering. Once it is known how elastin content of ECM guides cellular behavior (in 2D or 3D), one will be able to harness the power of collagen-elastin microenvironments to design and engineer stimuli-responsive tissues. Moreover, the implementation of such matrices to promote endothelial-mesenchymal transition of primary endothelial cells constitutes a powerful tool to engineer 3D tissues. Here, we design a 3D collagen-elastin scaffold to mimic the native ECM of heart valves, by providing the strength of collagen layers, as well as elasticity. Valve interstitial cells (VICs) were encapsulated in the collagen-elastin hydrogels and valve endothelial cells (VECs) cultured onto the surface to create an in vitro 3D VEC-VIC co-culture. Over a seven-day period, VICs had stable expression levels of integrin β1 and F-actin and continuously proliferated, while cell morphology changed to more elongated. VECs maintained endothelial phenotype up to day five, as indicated by low expression of F-actin and integrin β1, while transformed VECs accounted for less than 7% of the total VECs in culture. On day seven, over 20% VECs were transformed to mesenchymal phenotype, indicated by increased actin filaments and higher expression of integrin β1. These findings demonstrate that our 3D collagen-elastin scaffolds provided a novel tool to study cell-cell or cell-matrix interactions in vitro, promoting advances in the current knowledge of valvular endothelial cell mesenchymal transition.

scholarly journals Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review

2018 ◽  
Vol 18 (3) ◽  
pp. 264 ◽  
Author(s):  
Roberto Berebichez-Fridman ◽  
Pablo R. Montero-Olvera
Keyword(s):  
Tissue Engineering ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Regenerative Medicine ◽  
Adult Stem Cells ◽  
Current Knowledge ◽  
Clinical Applications ◽  
The Body ◽  
Differentiation Potential ◽  
Advantages And Disadvantages

First discovered by Friedenstein in 1976, mesenchymal stem cells (MSCs) are adult stem cells found throughout the body that share a fixed set of characteristics. Discovered initially in the bone marrow, this cell source is considered the gold standard for clinical research, although various other sources—including adipose tissue, dental pulp, mobilised peripheral blood and birth-derived tissues—have since been identified. Although similar, MSCs derived from different sources possess distinct characteristics, advantages and disadvantages, including their differentiation potential and proliferation capacity, which influence their applicability. Hence, they may be used for specific clinical applications in the fields of regenerative medicine and tissue engineering. This review article summarises current knowledge regarding the various sources, characteristics and therapeutic applications of MSCs.Keywords: Mesenchymal Stem Cells; Adult Stem Cells; Regenerative Medicine; Cell Differentiation; Tissue Engineering.

scholarly journals Proteins and Peptides as Important Modifiers of the Polymer Scaffolds for Tissue Engineering Applications—A Review

Polymers ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 844 ◽  
Author(s):  
Katarzyna Klimek ◽  
Grazyna Ginalska
Keyword(s):  
Tissue Engineering ◽  
Current Knowledge ◽  
Biological Properties ◽  
Synthetic Polymer ◽  
Bioactive Molecules ◽  
Matrix Proteins ◽  
Polymer Scaffolds ◽  
The Past ◽  
Proliferation And Differentiation ◽  
Proteins And Peptides

Polymer scaffolds constitute a very interesting strategy for tissue engineering. Even though they are generally non-toxic, in some cases, they may not provide suitable support for cell adhesion, proliferation, and differentiation, which decelerates tissue regeneration. To improve biological properties, scaffolds are frequently enriched with bioactive molecules, inter alia extracellular matrix proteins, adhesive peptides, growth factors, hormones, and cytokines. Although there are many papers describing synthesis and properties of polymer scaffolds enriched with proteins or peptides, few reviews comprehensively summarize these bioactive molecules. Thus, this review presents the current knowledge about the most important proteins and peptides used for modification of polymer scaffolds for tissue engineering. This paper also describes the influence of addition of proteins and peptides on physicochemical, mechanical, and biological properties of polymer scaffolds. Moreover, this article sums up the major applications of some biodegradable natural and synthetic polymer scaffolds modified with proteins and peptides, which have been developed within the past five years.

Gene Delivery for Periodontal Tissue Engineering: Current Knowledge – Future Possibilities

2009 ◽  
Vol 9 (4) ◽  
pp. 248-266 ◽  
Author(s):  
Fa-Ming Chen ◽  
Zhi-Wei Ma ◽  
Qin-Tao Wang ◽  
Zhi-Fen Wu
Keyword(s):  
Tissue Engineering ◽  
Gene Delivery ◽  
Current Knowledge ◽  
Periodontal Tissue

Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease

2015 ◽  
Vol 129 (12) ◽  
pp. 1107-1113 ◽  
Author(s):  
Francesca Zorzi ◽  
Emma Calabrese ◽  
Giovanni Monteleone
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Current Knowledge ◽  
Experimental Models ◽  
Human Beings ◽  
Intestinal Fibrosis ◽  
Bowel Diseases ◽  
Ecm Extracellular Matrix ◽  
Inflammatory Bowel ◽  
Related Proteins

In Crohn's disease, one of the two major forms of inflammatory bowel diseases in human beings, persistent and chronic inflammation promotes fibrotic processes thereby facilitating formation of strictures, the most common indication for surgical intervention in this disorder. The pathogenesis of Crohn's disease-associated fibrosis is not fully understood, but variants of genes involved in the recognition of microbial components/products [e.g. CARD15 (caspase-activating recruitment domain 15) and ATG16L1 (autophagy-related 16-like 1)] are associated with this phenotype, and experimental evidence suggests that intestinal fibrosis results from an altered balance between deposition of ECM (extracellular matrix) and degradation of ECM by proteases. Studies have also contributed to identify the main phenotypic and functional alterations of cells involved in the fibrogenic process, as well as molecules that stimulate such cells to produce elevated amounts of collagen and other ECM-related proteins. In the present review, we assess the current knowledge about cellular and molecular mediators of intestinal fibrosis and describe results of recent studies aimed at testing the preventive/therapeutic effect of compounds in experimental models of intestinal fibrosis.

Sign in / Sign up

Export Citation Format

Share Document